Searched over 200M research papers for "apo medicine"
7 papers analyzed
These studies suggest that apomorphine is used for addiction, erectile dysfunction, and Parkinson's disease, while apolipoprotein E (APOE) and Apo B are relevant in personalized medicine and cardiovascular disease prevention.
20 papers analyzed
Apomorphine (APO) is a versatile aporphine derivative with significant applications in both human and veterinary medicine. It functions primarily as a non-selective dopamine agonist, activating a range of dopamine receptors (D1, D2S, D2L, D3, D4, and D5), serotonin receptors (5HT1A, 5HT2A, 5HT2B, and 5HT2C), and α-adrenergic receptors (α1B, α1D, α2A, α2B, and α2C).
In veterinary medicine, APO is predominantly used to induce vomiting in dogs. This is a critical early treatment for the ingestion of certain poisons, such as antifreeze or insecticides, helping to prevent further absorption of the toxic substances.
One of the most significant uses of APO in human medicine is in the treatment of advanced Parkinson's disease (PD). APO is particularly effective for patients experiencing persistent and disabling motor fluctuations that do not respond to levodopa or other dopamine agonists. It can be used alone or in combination with deep brain stimulation to manage these symptoms. Studies have shown that continuous subcutaneous apomorphine infusion can significantly reduce off-time and the need for other antiparkinsonian drugs, with sustained effects over time. Additionally, a multicenter study comparing APO infusion with intrajejunal levodopa infusion (IJLI) found that both treatments provided robust improvements in motor symptoms, quality of life, and some non-motor symptoms, although each had different side effect profiles.
APO has also been explored for various other therapeutic applications. It has been used in the treatment of addiction to substances such as heroin, alcohol, and cigarettes, as well as for erectile dysfunction in males and hypoactive sexual desire disorder in females. Recently, there has been interest in its potential role in treating Alzheimer's disease, as APO appears to stimulate Aβ catabolism, reducing the rate of Aβ oligomerization and consequent neural cell death in animal models and cell cultures.
Apomorphine is a multifaceted drug with a wide range of applications in both human and veterinary medicine. Its primary use in treating advanced Parkinson's disease has been well-documented, providing significant improvements in motor and non-motor symptoms. Additionally, its potential roles in treating addiction, sexual dysfunction, and possibly Alzheimer's disease highlight its versatility and importance in medical therapeutics. Further research and controlled studies are necessary to fully understand and optimize its use across these various applications.
Most relevant research papers on this topic